Abstract

HIV-1 uses tRNA3Lys to prime reverse transcription of its viral RNA. In this process, the 3'-end of tRNA3Lys must be annealed to the primer binding site of HIV-1 genomic RNA, and the two molecules together form a complex structure. During annealing, the nucleocapsid (NC) protein enhances the unwinding of tertiary structures within both RNA molecules. Moreover, the packaging of tRNA3Lys occurs prior to viral budding at a time when NC is still part of the Pr55Gag polyprotein. In contrast, Pr55Gag is able to produce virus-like particles on its own. We have recently shown that an N-terminal extended form of NC (mGag), containing all of the minimal elements required for virus-like particle formation, possesses greater affinity for HIV-1 genomic RNA than does NC alone. We have now studied the tRNA3Lys-annealing properties of mGag in comparison to those of NC and report that the former is more efficient in this regard than the latter. We have also tested each of a mutant version of mGag, an extended form of mGag, and an almost full-length form of Gag, and showed that all of these possessed greater tRNA-annealing capacity than did the viral NC protein. Yet, surprisingly, multimerization of Gag-related proteins did not abrogate this annealing process but rather resulted in dramatically reduced levels of reverse transcriptase processivity. These results suggest that the initial stages of reverse transcription may be regulated by the multimerization of Pr55Gag polyprotein at times prior to the cleavage of NC.

Highlights

  • During the retrovirus life cycle, viral genomic RNA is retrotranscribed by the reverse transcriptase (RT)1 enzyme into a double-stranded cDNA, which is integrated into the host cell genome and forward transcribed to produce viral RNA and proteins

  • We have recently shown that an N-terminal extended form of NC, containing all of the minimal elements required for virus-like particle formation, possesses greater affinity for HIV-1 genomic RNA than does NC alone

  • We used a purified minimal Gag (mGag) protein containing all relevant motifs of Pr55Gag protein for virus-like particles (VLPs) formation, to study the annealing of tRNA3Lys onto the primer binding site (PBS) and the initiation of reverse transcription

Read more

Summary

Introduction

During the retrovirus life cycle, viral genomic RNA is retrotranscribed by the reverse transcriptase (RT) enzyme into a double-stranded cDNA, which is integrated into the host cell genome and forward transcribed to produce viral RNA and proteins. (HIV-1) uses human tRNA3Lys, one of three major tRNLys isoacceptors, for the priming of reverse transcription (1). TRNA3Lys is selectively incorporated into the virus particle and is annealed via 18 bases at its 3Ј-end to a complementary 18-base sequence near the 5Ј-end of viral genomic RNA termed the primer binding site (PBS) (2– 4). TRNA3Lys primes the synthesis of minus strand cDNA. Both tRNA3Lys and the PBS have complex three-dimensional structures, and the annealing of the two relevant sequences requires the “unwinding” of local stem-loop structures (6, 7). NC enhances local unwinding of tertiary structures in the vicinity of the PBS to allow the annealing of tRNA3Lys (see Fig. 1a) (9). NC binds to structures in viral RNA termed stem loop 1 (SL1) through SL4 to package HIV-1 genomic RNA (10 –14). NC contains two Zn2ϩ fingers that are required for both this genomic RNA recognition as well as for its roles in strand transfer (15)

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.